Evidence map›Paper›PMID 36110546›Full record

SynthesisFrontiers in pharmacology2022

The correlation between probiotic use and outcomes of cancer patients treated with immune checkpoint inhibitors.

Lilong Zhang, Qi Jin, Dongqi Chai, Tianrui Kuang, Chunlei Li, Yongjun Guan, Li Liu, Weixing Wang, Wenhong Deng

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Neutrophil-To-Lymphocyte Ratio as a Prognostic Indicator in Thyroid Cancer.Cancer control : journal of the Moffitt Cancer Center
    Pooled it
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Gut microbiota and immunotherapy of renal cell carcinoma.Human vaccines & immunotherapeutics · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lilong ZhangDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Qi JinDepartment of Neurology, The First Hospital of Jilin University, Changchun, China.
Dongqi ChaiDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Tianrui KuangDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Chunlei LiDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Yongjun GuanDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Li LiuDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Weixing WangDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Wenhong DengDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immune checkpoint inhibitorsmeta-analysisnon-small cell lung cancerprobioticsprognosis

Identifiers

PMID36110546
PMCPMC9468893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.